There’s no notification yet!
In our latest episode, we’re joined by Paul Steckler, Managing Director for Canopy Growth International. We discuss the challenges of fitting cannabis production into a traditional pharmaceutical medical framework, along with some of the biggest UK-centric, economic and market challenges associated with operating within this space.
This week, we’re joined by Valentino Parravicini, Chief Scientific Officer at Oxford Cannabinoid Technologies – British pharmaceutical company developing a portfolio of next-generation prescription cannabinoid medicines. In this episode, we explore the potential use of cannabis-based medicines as a replacement for prescription opioids, their safety profile, and their use cases as analgesics.
In our latest episode, we’re joined by Elana Goldberg, CEO of The Cannigma – online cannabis content publication with a focus on scientific research and evidence. We dig into the topic of cannabis misinformation, including what The Cannigma are doing to combat it, why a science-based educational approach to cannabis education is best, and the … Read more
On the latest episode of The Cannabis Conversation, we’re joined by Dr. Callie Seaman, Research Director and Formulation Chemist at AquaLabs – nutrient solution provider to the hobby and medical horticultural market, and UK licensed medical cannabis cultivation research facility. We investigate some of the biggest cannabis myths, including why cannabis should not be seen … Read more
“I deal with very sick patients that have been to multiple doctors and have tried everything that’s been approved or everything that’s been tried — and I have to offer them hope,” says Dr. Roni Sharon. “Very often I’ll offer them medical marijuana.” In this episode of The Cannabis Enigma, we speak with Dr. Roni … Read more
Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. Despite this, being in possession of a prescription is the only way that cannabis can be legally consumed. Though hopefully this will not be the case for much longer. … Read more
This week we’re joined by Dr Dani Gordon, Founder and Medical Director of Resilience.Clinic – specialising in the treatment of complex multi-symptom conditions which affect mood, energy, mental function (brain fog), stress, pain, sleep, and digestion. Together, we explore some of the conditions medical cannabis can help with, the non-medical interventions that form part of … Read more
This week, we’re joined by Dr. Paola Cubillos – Colombian-Canadian integrative medicine physician, Medical Cannabis doctor and educator. We investigate the existing theory and evidence base behind the concept of ‘The Entourage Effect’ as coined by Professor Raphael Mechoulam, alongside the data we need to be able to validate the hypothesis.
When you go to the pharmacy to fill a prescription, the pharmacist checks to see if there could be any adverse drug interactions. Your doctor usually does the same. Do we need to be treating medical marijuana similarly? And who should be responsible? Dr. Roni Sharon speaks about how cannabis interacts with other medications, how … Read more
This week we’re joined by pharmacologist Dr Saoirse O’Sullivan and pharmacist Dr Andy Yates, experienced cannabis scientists and advisors to Artelo Biosciences. In this episode we take an in-depth look into cannabinoids, exploring the three classes – endocannabinoids, phytocannabinoids and synthetic cannabinoids in detail, alongside the uses, benefits and limitations of each type.
